Pure Global AI
NCT05902117Recruiting

Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS

Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS in the Management of Pre-hospital and In-hospital Non-traumatic Chest Pain in Adults
Hôpital NOVOClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Acute Myocardial Infarction
Drug/Device/Intervention
Troponin and Copeptin assay
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Hôpital NOVO
Location
Pontoise,Pontoise, France
Timeline & enrollment
Phase
N/A
Start date
Jun 28, 2023
End date
Sep 01, 2024
Enrollment
270 participants
Primary outcome

Demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old (sensitivity/specificity),Demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old (negative predictive value)

Summary

The aim of this study is to demonstrate that a combined troponin and copeptin assay can
 exclude non-ST+ ACS in patients with chest pain less than 6 hours old.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionCertain current complications following acute myocardial infarctionOther current complications following acute myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05902117
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05902117 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital NOVO and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 270 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.